McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Oath Surgical Raises $24M to Build the First Surgeon-Owned, AI-Powered Surgical System

by McKesson Ventures | Oct 6, 2025 | Portfolio News, Press Releases

AI-powered surgical care innovator Oath Surgical recently announced that it has secured $24 million in Series A funding, led by FPV Ventures alongside McKesson Ventures and existing investors OSE, Black Opal Ventures, Tau Ventures, and Rogue VC — bringing the...

Lumata Health Improves Patient Adherence to Vision-Saving Treatments by Alleviating Barriers to Care

by McKesson Ventures | Sep 30, 2025 | Press Releases

Ophthalmology and optometry management provider Lumata Health recently announced the results of its new research report “Lumata’s Continuous Care Program Demonstrates Increased Appointment Attendance by Addressing Barriers to Care.” This report found that patients who...

Saama Introduces Modular and Adaptive AI Agents For Clinical Innovation

by McKesson Ventures | Sep 29, 2025 | Press Releases

AI-driven solutions and services provider Saama has announced the introduction of Clinical AI Agents — a modular, industry-first approach to rapidly increase innovation and efficiency for existing platform investments. These Clinical Agents, developed using Saama’s...

Komodo Health Introduces Marmot, the AI Built to Accelerate Healthcare Innovation

by McKesson Ventures | Aug 20, 2025 | Press Releases

AI-powered healthcare intelligence company Komodo Health has announced the launch of Marmot™—a healthcare-native AI engine that uses healthcare analytics and real-world data to provide actionable insights to Life Sciences and healthcare teams within minutes. This...

Atropos Health Enters into Strategic Collaboration to Reduce Time to Rare Disease Diagnosis with Artificial Intelligence (AI) Algorithm

by McKesson Ventures | Aug 18, 2025 | Press Releases

On Monday, August 18th, real-world clinical data company Atropos Health announced that it has partnered with innovative medicines company Novartis to help train and improve medical AI models used to detect paroxysmal nocturnal hemoglobinuria (PNH). This rare disease...
Page 3 of 144«12345...102030...»Last »

Recent Posts

  • Atropos Health CEO Brigham Hyde Discusses Healthcare and Medical Technology Trends With McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
  • Latent Raises $80M to Close the Gap Between Diagnosis and Treatment
  • Midi Health Surpasses $1B Valuation, Igniting a New Era for Women’s Health
  • Oath Surgical Announces AI-Native Surgical Centers Powered by NVIDIA
  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings